10.6084/m9.figshare.10078130.v1 Paul Emery Paul Emery Daniel E. Furst Daniel E. Furst Petra Kirchner Petra Kirchner Simone Melega Simone Melega Stuart Lacey Stuart Lacey Patricia B. Lehane Patricia B. Lehane Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data Adis Journals 2019 Database Malignancy Real-world Rheumatoid arthritis Rituximab Safety 2019-11-18 13:26:44 Figure https://adisjournals.figshare.com/articles/figure/Risk_of_Malignancies_in_Patients_with_Rheumatoid_Arthritis_Treated_with_Rituximab_Analyses_of_Global_Postmarketing_Safety_Data_and_Long-Term_Clinical_Trial_Data/10078130 <p><strong>Provide enhanced digital features for this article</strong><br></p><p> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides</p>